Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Cash from Investing Activities (2014 - 2023)

Mesoblast's (MEOBF) quarterly Cash from Investing Activities came in at $16000.0 in Q2 2023, up 134.04% year-over-year from $6836.4 in Q2 2022, and down 40.74% quarter-over-quarter from $27000.0 in Q1 2023.

Analysis

Mesoblast (MEOBF) Cash from Investing Activities (2014 - 2023) Analysis & Trends

Mesoblast has disclosed Cash from Investing Activities across 10 years of filings, most recently posting $16000.0 for Q2 2023.

  • In Q2 2023, Cash from Investing Activities rose 134.04% year-over-year to $16000.0; the TTM figure through Jun 2023 stood at -$194000.0 (up 16.38% YoY), while the FY2026 annual figure was -$1.0 million, down 952.5% from the prior year.
  • Cash from Investing Activities came in at $16000.0 for Q2 2023 at Mesoblast, down from $27000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $27000.0 in Q1 2023 to a low of -$1.4 million in Q1 2020.
  • Average Cash from Investing Activities over 5 years is -$283312.5, with a median of -$94500.0 recorded in 2019.
  • Year-over-year, Cash from Investing Activities tumbled 1461.11% in 2020 and jumped 148.21% in 2023.
  • Over 5 years, Cash from Investing Activities stood at -$712000.0 in 2019, then soared by 42.84% to -$407000.0 in 2020, then jumped by 92.63% to -$30000.0 in 2021, then slipped by 13.33% to -$34000.0 in 2022, then surged by 147.06% to $16000.0 in 2023.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $16000.0 in Q2 2023, $27000.0 in Q1 2023, and -$34000.0 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -161.58 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -55.66 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -74.05 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -120.00 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 53.26 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -9.88 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 26.69 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -93.37 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn -2.82 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 16,000.00
Mar 31, 2023 27,000.00
Dec 31, 2022 -34,000.00
Sep 30, 2022 -203,000.00
Jun 30, 2022 -47,000.00
Mar 31, 2022 -56,000.00
Dec 31, 2021 -30,000.00
Sep 30, 2021 -99,000.00
Jun 30, 2021 -223,000.00
Mar 31, 2021 -936,000.00
Dec 31, 2020 -407,000.00
Sep 30, 2020 -81,000.00
Mar 31, 2020 -1.41 Mn
Dec 31, 2019 -712,000.00
Sep 30, 2019 -253,000.00
Mar 31, 2019 -90,000.00
Dec 31, 2018 141,000.00
Sep 30, 2018 -39,000.00
Jun 30, 2018 -436,000.00
Mar 31, 2018 -37,000.00